Cargando…
SETDB1 regulates SMAD7 expression for breast cancer metastasis
Breast cancer (BRC) is the most invasive cancer in women. Although the survival rate of BRC is gradually increasing due to improved screening systems, development of novel therapeutic targets for inhibition of BRC proliferation, metastasis and recurrence have been constantly needed. Thus, in this st...
Autores principales: | Ryu, Tae Young, Kim, Kwangho, Kim, Seon-Kyu, Oh, Jung-Hwa, Min, Jeong-Ki, Jung, Cho-Rok, Son, Mi-Young, Kim, Dae-Soo, Cho, Hyun-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443319/ https://www.ncbi.nlm.nih.gov/pubmed/30545440 http://dx.doi.org/10.5483/BMBRep.2019.52.2.235 |
Ejemplares similares
-
Epigenetic regulation of SMAD3 by histone methyltransferase SMYD2 promotes lung cancer metastasis
por: Kim, Kwangho, et al.
Publicado: (2023) -
The novel prognostic marker, EHMT2, is involved in cell proliferation via HSPD1 regulation in breast cancer
por: Kim, Seon-Kyu, et al.
Publicado: (2018) -
EHMT1 knockdown induces apoptosis and cell cycle arrest in lung cancer cells by increasing CDKN1A expression
por: Lee, Jinkwon, et al.
Publicado: (2021) -
Novel prognostic marker PRMT1 regulates cell growth via downregulation of CDKN1A in HCC
por: Ryu, Jea-Woon, et al.
Publicado: (2017) -
Hypoxia stabilizes SETDB1 to maintain genome stability
por: Park, Sungryul, et al.
Publicado: (2023)